Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Virus Research

• Publication date

  1990-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0168-1702(90)90045-DPMID 2349834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-protection against microvariants of influenza virus type B by vaccinia viruses expressing haemagglutinins from egg- or MDCK cell-derived subpopulations of influenza virus type B/England/222/82.

  1989cited by this paper
• Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.

  1988cited by this paper
• Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1

  1988cited by this paper
• Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).

  1988cited by this paper
• Protection against lethal influenza with neuraminidase.

  1988cited by this paper
• Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection

  1988cited by this paper
• Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus

  1987cited by this paper
• Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus.

  1987cited by this paper
• Vaccinia virus expression vectors.

  1986cited by this paper
• Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections

  1986cited by this paper
• Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector.

  1986cited by this paper
• Supercoil Sequencing: A Fast and Simple Method for Sequencing Plasmid DNA

  1985cited by this paper
• Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

  1985cited by this paper
• Supercoil sequencing: a fast method for sequencing plasmid DNA

  1985cited by this paper
• Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers.

  1984cited by this paper
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

  1984cited by this paper
• Immune responses in serum and respiratory secretions following vaccination with a live cold‐recombinant (cr35) and inactivated a/ussr/77 (h1n1) influenza virus vaccine

  1983cited by this paper
• Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

  1983cited by this paper
• Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth.

  1983cited by this paper
• Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

  1983cited by this paper
• Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R.

  1982cited by this paper
• Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection.

  1981cited by this paper
• Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

  1980cited by this paper
• Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in mice

  1980cited by this paper
• Immune responses to influenza virus in the mouse, and their role in control of the infection.

  1979cited by this paper
• Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis

  1979cited by this paper
• Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures

  1979cited by this paper
• Control of influenza and poliomyelitis with killed virus vaccines.

  1977cited by this paper
• Differences in RNA patterns of influenza A viruses

  1976cited by this paper
• Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.

  1973cited by this paper
• Influenza immunization: field trial on a university campus.

  1972cited by this paper
• A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.

  1971cited by this paper
• A COMPARISON OF SUBCUTANEOUS, NASAL, AND COMBINED INFLUENZA VACCINATION. II. PROTECTION AGAINST NATURAL CHALLENGE12

  1971cited by this paper
• An evaluation of influenza immunization: influence of route of administration and vaccine strain.

  1969cited by this paper
• Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated Virus

  1968cited by this paper
• Air-borne influenza virus A infections in immunized animals.

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Fighting the flu in the tropics: The role of influenza vaccination in Southeast Asia

  2025cites this paper
• Advances in novel influenza vaccines: a patent review

  2016cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines

  2006cites this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cites this paper
• Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.

  2001cites this paper
• Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting.

  2001cites this paper
• Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract

  2000cites this paper
• Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.

  1997cites this paper
• Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

  1995cites this paper
• Poxvirus‐based vaccine candidates for cancer, AIDS, and other infectious diseases

  1995cites this paper
• Enteric immunization of mice against influenza with recombinant vaccinia.

  1994cites this paper
• Murine model for evaluation of protective immunity to influenza virus.

  1993cites this paper
• Recombinant vaccinia immunization in the presence of passively administered antibody.

  1993cites this paper
• Pharmaceutical applications

  1991cites this paper